The final programme is available here.
Programme at a Glance
| Saturday 10 May 2025 | |
|---|---|
| 13.00-13.45 | Opening Lecture by the Hungarian Host Past, present and future of the ALL-IC BFM trials Cszongor Kiss (HU), Gabor Kovacs (HU) |
| 14.00-16.10 | Myeloid Disorders How molecular-genetics shaped the diagnosis and current treatment of JMML Charlotte Niemeyer (DE) Oral Abstracts (4) |
| 16.10-16.30 | Coffee break |
| 16.30-18.40 | Acute Lymphoblastic Leukemia Is intensive chemotherapy needed for cure of primary acute lymphoblastic leukemia? Andrea Biondi (IT) Oral Abstracts (4) |
| Sunday 11 May 2025 | |
|---|---|
| 8.30-10.40 | Acute Lymphoblastic Leukemia Shall we sequence all patients with leukemia for known cancer predisposition genes? Jette Bakhuizen (NL) Oral Abstracts (4) |
| 10.40-11.00 | Coffee break |
| 11.00-12.40 | ALL Continued/Non-Hodgkin’s Lymphoma How molecular-genetics complement stage of disease in stratification of pediatric NHL Birgit Burkhardt (DE) Oral Abstracts (3) |
| 12.40-13.30 | Lunch |
| 13.30-16.00 | Poster Session |
| 16.00-16.30 | Coffee break |
| 16.30-18.10 | Cellular Therapies CART-cell therapy lessons learned from the GoCART Real World Data of the EBMT Adriana Balduzzi (IT) Oral abstracts (3) |